Physician profile
Andrew E Baker
NPI 1821618380
$930.49
in general payments reported to CMS, 2019-2025
13 companies · $76.89 in 2025
The $76.89 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $29.03 · 2023: $346 · 2024: $359 · 2025: $76.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $339.49 | 2023-2024 | Nalu Neurostimulation System |
| Smith+Nephew, INC. | $193.44 | 2022-2024 | Pico, Evos, Evos Mini |
| Sanofi-Aventis U.S. LLC | $125.00 | 2024 | |
| Stryker Corporation | $60.46 | 2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Abbvie INC. | $40.03 | 2021 | |
| Medacta USA, INC. | $37.39 | 2025 | Mecta |
| Supernus Pharmaceuticals, INC. | $26.63 | 2021 | |
| Ethicon US, LLC | $20.45 | 2025 | Ethicon |
| Redhill Biopharma INC. | $19.66 | 2021 | |
| Arcutis Biotherapeutics, INC. | $19.05 | 2025 | Zoryve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.50 | 2021 | |
| Medtronic, INC. | $15.96 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.